Safe and Effective Use of SGLT2is and GLP-1RAs in Your Cardiology Practice
Listen to expert faculty discuss the paradigm shift for cardiologists in understanding how to use SGLT2is and GLP-1RAs safely and effectively in their practice. This discussion focuses on when and how to safely commence these drugs, as well as when and how to engage other members of the care team.
Educational grant support provided by: Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
To visit the hub for the CV Risk in Diabetes: Emerging Science Grant, click here!
Keywords: Primary Prevention, Diabetes Mellitus, Dyslipidemias, Sodium-Glucose Transporter 2
< Back to Listings